RxDoctor Payments Data

Carolina Rocha, PA

Physician Assistant · Deerfield Beach, FLNPI 1457946493

Payments from drug & device makers

$5,048in general payments, 2019–2025

Across 221 payments — averaging $22.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$969
  • Boehringer Ingelheim$879
  • Novartis$694
  • Amgen$457
  • E.r. Squibb & Sons, L.L.C.$434
  • Johnson & Johnson$316
  • plus $1K from 18 others

What the payments were for

  • Travel & lodging$271%
  • Food & beverage$5,02199%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,048 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$18,496
Medicare patients
214
Services billed
300

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban83$91,374
EntrestoSacubitril/Valsartan26$33,400
JardianceEmpagliflozin17$14,616
Amlodipine Besylate140$1,414
Atorvastatin Calcium107$1,082
Losartan Potassium108$959
Metoprolol Succinate105$956
Carvedilol95$711
Rosuvastatin Calcium58$635
Lisinopril50$389
Ezetimibe32$374
Spironolactone25$360
Hydralazine Hcl21$251
Nifedipine ErNifedipine15$178
Hydrochlorothiazide33$173

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$140$91,37483 claims
NovartisEntresto$694$33,40026 claims
Boehringer IngelheimJardiance$879$14,61617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Deerfield Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →